Exceptions to fully informed consent in clinical Research

K. E. Larsen, Daniel E. Hilleman

Research output: Contribution to journalArticle

Abstract

The doctrine of informed consent is fundamental to all medical personnel involved in investigational research. Informed consent arose from the Helsinki declaration that stated, "concern for the interests of the subject must always prevail over the interests of science and society." (6) As clinical research is a part of medical practice, it is reasonable to assume that exceptions to fully informed consent that are defendable in medical practice can be applied to clinical research as well. The exceptions to fully informed consent are waiver, incompetence, therapeutic priviledge, emergency, or proxy.

Original languageEnglish
Pages (from-to)99-112
Number of pages14
JournalClinical Research and Regulatory Affairs
Volume8
Issue number2
DOIs
StatePublished - 1990

Fingerprint

Informed Consent
Research
Helsinki Declaration
Proxy
Emergencies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacology (medical)

Cite this

Exceptions to fully informed consent in clinical Research. / Larsen, K. E.; Hilleman, Daniel E.

In: Clinical Research and Regulatory Affairs, Vol. 8, No. 2, 1990, p. 99-112.

Research output: Contribution to journalArticle

@article{4660515f0ff2409ba0543f0bdde68e36,
title = "Exceptions to fully informed consent in clinical Research",
abstract = "The doctrine of informed consent is fundamental to all medical personnel involved in investigational research. Informed consent arose from the Helsinki declaration that stated, {"}concern for the interests of the subject must always prevail over the interests of science and society.{"} (6) As clinical research is a part of medical practice, it is reasonable to assume that exceptions to fully informed consent that are defendable in medical practice can be applied to clinical research as well. The exceptions to fully informed consent are waiver, incompetence, therapeutic priviledge, emergency, or proxy.",
author = "Larsen, {K. E.} and Hilleman, {Daniel E.}",
year = "1990",
doi = "10.3109/10601339009024025",
language = "English",
volume = "8",
pages = "99--112",
journal = "Clinical Research Practices and Drug Regulatory Affairs",
issn = "1060-1333",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Exceptions to fully informed consent in clinical Research

AU - Larsen, K. E.

AU - Hilleman, Daniel E.

PY - 1990

Y1 - 1990

N2 - The doctrine of informed consent is fundamental to all medical personnel involved in investigational research. Informed consent arose from the Helsinki declaration that stated, "concern for the interests of the subject must always prevail over the interests of science and society." (6) As clinical research is a part of medical practice, it is reasonable to assume that exceptions to fully informed consent that are defendable in medical practice can be applied to clinical research as well. The exceptions to fully informed consent are waiver, incompetence, therapeutic priviledge, emergency, or proxy.

AB - The doctrine of informed consent is fundamental to all medical personnel involved in investigational research. Informed consent arose from the Helsinki declaration that stated, "concern for the interests of the subject must always prevail over the interests of science and society." (6) As clinical research is a part of medical practice, it is reasonable to assume that exceptions to fully informed consent that are defendable in medical practice can be applied to clinical research as well. The exceptions to fully informed consent are waiver, incompetence, therapeutic priviledge, emergency, or proxy.

UR - http://www.scopus.com/inward/record.url?scp=84907035128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907035128&partnerID=8YFLogxK

U2 - 10.3109/10601339009024025

DO - 10.3109/10601339009024025

M3 - Article

VL - 8

SP - 99

EP - 112

JO - Clinical Research Practices and Drug Regulatory Affairs

JF - Clinical Research Practices and Drug Regulatory Affairs

SN - 1060-1333

IS - 2

ER -